Differential Role of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein in Toll-Like Receptor 2-Mediated Regulation of Gene Expression of Hepatic Cytokines and Drug-Metabolizing Enzymes
Open Access
- 8 February 2011
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 39 (5), 874-881
- https://doi.org/10.1124/dmd.110.037382
Abstract
Pharmacological activities of drugs are impaired during inflammation because of reduced expression of hepatic drug-metabolizing enzyme genes (DMEs) and their regulatory nuclear receptors (NRs): pregnane X receptor (PXR), constitutive androstane receptor (CAR), and retinoid X receptor (RXRα). We have shown that a component of Gram-positive bacteria, lipoteichoic acid (LTA) induces proinflammatory cytokines and reduces gene expression of hepatic DMEs and NRs. LTA is a Toll-like receptor 2 (TLR2) ligand, which initiates signaling by recruitment of Toll-interleukin 1 receptor domain-containing adaptor protein (TIRAP) to the cytoplasmic TIR domain of TLR2. To determine the role of TIRAP in TLR2-mediated regulation of DME genes, TLR2(+/+), TLR2(−/−), TIRAP(+/+), and TIRAP(−/−) mice were given LTA injections. RNA levels of the DMEs (Cyp3a11, Cyp2b10, and sulfoaminotransferase), xenobiotic NRs (PXR and CAR), and nuclear protein levels of the central NR RXRα were reduced ∼50 to 60% in LTA-treated TLR2(+/+) but not in TLR2(−/−) mice. Induction of hepatic cytokines (interleukin-1β, tumor necrosis factor-α, and interleukin-6), c-Jun NH2-terminal kinase, and nuclear factor-κΒ was blocked in TLR2(−/−) mice. As expected, expression of hepatic DMEs and NRs was reduced by LTA in TIRAP(+/+) but not in TIRAP(−/−) mice. Of interest, cytokine RNA levels were induced in the livers of both the TIRAP(+/+) and TIRAP(−/−) mice, whereas LTA-mediated induction of serum cytokines was attenuated in TIRAP(−/−) mice. LTA-mediated down-regulation of DME genes was attenuated in hepatocytes from TLR2(−/−) or TIRAP(−/−) mice and in small interfering RNA-treated hepatocytes. Thus, the effect of TLR2 on DME genes in hepatocytes was mediated by TIRAP, whereas TIRAP was not involved in mediating the effects of TLR2 on cytokine expression in the liver.Keywords
This publication has 41 references indexed in Scilit:
- Nuclear receptors in drug metabolism and beyondDrug Metabolism Reviews, 2013
- Pattern Recognition Receptors and InflammationCell, 2010
- Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and PharmacokineticsClinical Pharmacology & Therapeutics, 2009
- Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanismHepatology, 2009
- Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acidArchives of Biochemistry and Biophysics, 2009
- β2-Integrin-induced p38 MAPK Activation Is a Key Mediator in the CD14/TLR4/MD2-dependent Uptake of Lipopolysaccharide by HepatocytesOnline Journal of Public Health Informatics, 2008
- Activation of hepatocytes by extracellular heat shock protein 72American Journal of Physiology-Cell Physiology, 2008
- Mutual repression between steroid and xenobiotic receptor and NF- B signaling pathways links xenobiotic metabolism and inflammationJCI Insight, 2006
- Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor SignalingCell, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004